| 000 | 01452 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517131037.0 | ||
| 264 | 0 | _c20180213 | |
| 008 | 201802s 0 0 eng d | ||
| 022 | _a1464-5491 | ||
| 024 | 7 |
_a10.1111/dme.13299 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDunger, D B | |
| 245 | 0 | 0 |
_aBanting Memorial Lecture 2016 Reducing lifetime risk of complications in adolescents with Type 1 diabetes. _h[electronic resource] |
| 260 |
_bDiabetic medicine : a journal of the British Diabetic Association _c04 2017 |
||
| 300 |
_a460-466 p. _bdigital |
||
| 500 | _aPublication Type: Lecture; Review | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAngiotensin-Converting Enzyme Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xetiology |
| 650 | 0 | 4 |
_aDiabetes Complications _xetiology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 | _aInsulin Infusion Systems |
| 650 | 0 | 4 | _aRisk Reduction Behavior |
| 773 | 0 |
_tDiabetic medicine : a journal of the British Diabetic Association _gvol. 34 _gno. 4 _gp. 460-466 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/dme.13299 _zAvailable from publisher's website |
| 999 |
_c26697005 _d26697005 |
||